Growth and hormones after childhood cancer treatment
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This study compares growth and hormone development in children treated for cancer before puberty, with or without a stem cell transplant. It aims to understand how these treatments affect long-term growth and puberty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for childhood cancer between 2005 and 2020.
- You had not started puberty at the time of treatment (testicles < 4 ml, uterus < 2.5 ml).
- You received chemotherapy that included drugs like cyclophosphamide, ifosfamide, or similar.
- You went through puberty on your own, without needing hormone shots or patches.
- You had follow-up care at the Endocrine-Metabolic Diseases Program in Bologna, Italy.
- You did not need hormone therapy because puberty was delayed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a personalized goal-setting tool helps children and teens recovering from a stem cell transplant. It is designed for young patients with cancer or blood disorders who are not already in rehab.
This study tests whether exercise and health counseling can help children and young people recovering from a stem cell transplant for cancer. Participants will be assigned to either the exercise program or standard care, and the study will see how it affects their recovery and quality of life.
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
This study looks at whether a blood test (a hormone marker) can predict a child’s future risk of infertility after cancer treatment. If it works, it could help families and doctors plan earlier fertility and puberty-related care.
This trial is studying better ways to manage stem cell transplants for children and young adults with acute lymphoblastic leukemia (ALL). It aims to improve outcomes by testing different approaches to transplant care.
This trial studies a special donor stem cell transplant where the donor’s immune cells are reduced, aiming to lower harmful immune attacks after transplant. It may help children and young adults with certain high-risk blood cancers or rare bone marrow disorders.
Hear when a new Pediatrics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.